March 8, 2012
Mitsubishi Tanabe Pharma Corporation (MTPC) announced on March 7 that it has entered into an agreement with Canadian biotechnology company Medicago Inc. (located in Quebec) to conduct joint research on new next-generation vaccines. Using Medicago’s virus-like particles (VLPs) manufacturing technology,...read more